Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy

Hanifin, 1980, Diagnostic features of atopic dermatitis, Acta Derm Venereol Suppl (Stockh), 92, 44, 10.2340/00015555924447 Bos, 1996, Atopic dermatitis, J Eur Acad Dermatol Venereol, 7, 101, 10.1111/j.1468-3083.1996.tb00605.x Su, 1997, Atopic eczema: its impact on the family and financial cost, Arch Dis Child, 76, 159, 10.1136/adc.76.2.159 Laughter, 2000, The prevalence of atopic dermatitis in Oregon schoolchildren, J Am Acad Dermatol, 43, 649, 10.1067/mjd.2000.107773 Boguniewicz, 1996, New concepts in atopic dermatitis, Compr Ther, 22, 144 Rudikoff, 1998, Atopic dermatitis, Lancet, 351, 1715, 10.1016/S0140-6736(97)12082-7 Sidbury, 2000, Old, new, and emerging therapies for atopic dermatitis, Dermatol Clin, 38, 1, 10.1016/S0733-8635(05)70141-8 Bird, 1996, New therapeutic approaches to atopic der-matitis, Exp Opin Invest Drugs, 5, 1173, 10.1517/13543784.5.9.1173 Leung, 1997, Disease management of atopic dermatitis: a practice parameter, Ann Allergy Asthma Immunol, 79, 197, 10.1016/S1081-1206(10)63003-7 Liu, 1991, Calcineurin is a common target of cyclophilin-cyclosporine A and FKBP-FK506 complexes, Cell, 66, 807, 10.1016/0092-8674(91)90124-H Schreiber, 1992, The mechanism of action of cyclosporine A and FK506, Immunol Today, 13, 136, 10.1016/0167-5699(92)90111-J Hanifin, 1999, Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies, J Am Acad Dermatol, 41, 72, 10.1016/S0190-9622(99)70410-X Takamatsu, 1998, IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis, Dermatology, 196, 377, 10.1159/000017928 Lawrence, 1998, Tacrolimus (FK506): experience in dermatology, Dermatol Ther, 5, 74 Leung, 1996, The immunology of atopic dermatitis, 113 Ruzicka, 1997, A short-term trial of tacrolimus ointment for atopic dermatitis, N Engl J Med, 337, 816, 10.1056/NEJM199709183371203 Alaiti, 1998, Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children, J Am Acad Dermatol, 38, 69, 10.1016/S0190-9622(98)70541-9 Boguniewicz, 1998, A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children, J Allergy Clin Immunol, 102, 637, 10.1016/S0091-6749(98)70281-7 Nakagawa, 1994, Tacrolimus ointment for atopic dermatitis [letter], Lancet, 344, 883, 10.1016/S0140-6736(94)92855-X Aoyama, 1995, Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment [letter], Br J Dermatol, 133, 494, 10.1111/j.1365-2133.1995.tb02691.x Reitamo, 1998, Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial, J Invest Dermatol, 111, 396, 10.1046/j.1523-1747.1998.00323.x Rajka, 1989, Grading of the severity of atopic dermati-tis, Acta Derm Venereol Suppl (Stockh), 144, 13 Cherill, 1998, Eczema area and severity index (EASI): a new tool to evaluate atopic dermatitis [abstract], J Eur Acad Dermatol Venereol, 11, 48 Berardesca, 1996, Racial differences in skin pathophysiology, J Am Acad Dermatol, 34, 667, 10.1016/S0190-9622(96)80070-3 La Ruche, 1992, Histology and physiology of black skin [Histologie et physiologie de la peu noire], Ann Dermatol Venereol, 119, 567 Kompaore, 1993, In vivo differences between Asian, Black and White in the stratum corneum barrier function, Int Arch Occup Environ Health, 65, S223, 10.1007/BF00381346 Soter, 2001, Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety, J Am Acad Dermatol, 44, S39, 10.1067/mjd.2001.109817